O

Organovo Holdings
D

ONVO

0.39020
USD
0.04
(12.45%)
مغلق
حجم التداول
2,188
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
5,995,745
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    E
    EXAS
    -1.680
    (-3.29%)
    49.330 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    P
    PACB
    -0.25500
    (-13.78%)
    1.59500 USD
    S
    STEM
    -0.02100
    (-5.60%)
    0.35400 USD
    T
    TDOC
    0.23500
    (2.62%)
    9.19500 USD
    V
    VCEL
    -0.240
    (-0.46%)
    52.510 USD
    المزيد
الأخبار

العنوان: Organovo Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.